Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

Market Nav

SAMRAT PHARMACHEM LTD.

  • NSE Code-
  • BSE Code530125
  • ISININE103E01016
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

16/06/1992

Registered Address


Ankleshwar, Gujarat - 393002
Tel: 02646-220774
Fax: 02646-251291

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Corporate News

Samrat Pharma - Board Meeting Intimation for Notice O...

30-Jun-2026|3:11PM

Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Dir

Samrat Pharma posts Q4 net loss of Rs 2.04 cr

01-Jun-2026|11:40AM

The company reported standalone net loss during the quarter stood at Rs 2.0

Samrat Pharma - Board Meeting Outcome for Outcome Of ...

30-May-2026|8:49PM

The Board considered and adopted the financial results for the quarter and

Samrat Pharma - Audited Financial Results For The Qua...

30-May-2026|8:46PM

Audited Financial Results for the quarter and year ended 31st March, 2026

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug86.56245.43
Aarti Drug379.703,465.52
Aarti Pharma705.356,396.10
Abbott India26,860.0057,075.63
Accent Micro509.401,222.00

MF Holding

No Data Available

Board Meetings

DatePurpose
14/08/2026Quarterly Results
30/05/2026Audited Results
13/02/2026Quarterly Results
14/11/2025Quarterly Results
13/08/2025Quarterly Results